In a groundbreaking achievement, scientists have developed the first gene-editing medicine tailored for a baby suffering from a rare DNA condition. After successful treatments, KJ Muldoon is now healthier and ready to go home, showcasing a promising future for gene therapies.
KJ Muldoon, born with a deadly genetic disorder, received a groundbreaking CRISPR treatment just six months after birth. His remarkable progress showcases the future of personalized medicine for rare diseases.
